Phage Therapy: Bacteriophages as Natural, Self-Replicating Antimicrobials

Practical Handbook of Microbiology: Second Edition

Volumn , Issue , 2008, Pages 713-730

  Kutter, Elizabeth ^a  

^a EVERGREEN STATE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85153642470     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420009330-52     Document Type: Chapter

References (82)

1. Levin, B., Bull, J.J., Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics, Am. Nat., 147: 881-898, 1996.
2. Radetsky, P., The good virus, Discover, 17: 50-58, 1996.
3. Barrow, P.A. and Soothill, J.S., Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of the potential, Trends Microbiol., 5: 268-271, 1997.
4. Alisky, J., Iczkonski, K., Rapoport, A., and Troitsky, N., Bacteriophage shows promise as antimicrobial agents, J. Infection, 36: 5-13, 1998.
5. Sulakvelidze, A., Alavidze, Z., and Morris, J., Bacteriophage therapy, Antimicrob. Agents Chemother., 45: 649-659, 2001.
6. Summers, W.C., Felix d’Herelle and the Origins of Molecular Biology, New Haven, CT: Yale University Press, 1999.
7. Kutter, E. and Sulakvelidze, A., Bacteriophages: Biology and Applications. Boca Raton, FL: CRC Press, 2005.
8. Merril, C.R., Scholl, D., and Adhya, S.L., The prospect for bacteriophage therapy in Western medicine, Nat. Rev. Drug Discov., 2: 489-497, 2003.
9. Bruessow, H., Phage therapy: the Western perspective, in Bacteriophage Genetics and Molecular Biology. S. McGrath and D. van Sinderen, Eds., Caister Academic Press, Norfolk, UK, 2007, 159-192.
10. Gorski, A., Borysowski, J., Miedzybrodzki, R., and Weber-Dabrowska, B., Bacteriophages in medicine, in Bacteriophage Genetics and Molecular Biology. S. McGrath and D. van Sinderen, Eds., Caister Academic Press, Norfolk, UK, 2007, 125-158.
11. Hausler T., Viruses vs. Superbugs: A Solution to the Antibiotics Crisis? (originally published in German:Häusler T., Gesund durch Viren. Piper, Munchen, Germany, 2003), 2006.
12. Entenza, J.M., Loeffler, J.M., Grandgirard, D., Fischetti, V.A., and Moreillon, P., Therapeutic effects of bacteriophage CPL-1 lysin against Streptococcus pneumoniae endocarditis in rats, Antimicrob. Agents Chemother., 49: 4789-4792, 2005.
13. D’Herelle, F. (Smith, G.H., translated), The Bacteriophage: Its Role in Immunity. Williams and Wilkins Company, Baltimore, MD, 1922.
14. Bruynoghe, R. and Maisin, J., Essais de therapeutique au moyen du bacteriophage du staphylocoque, C.R. Soc. Biol., 85: 1120-1121, 1921.
15. D’Herelle, F., The Bacteriophage and Its Clinical Applications. Springfield, IL: CC Thomas, 1930.
16. D’Herrelle, F. (Eliava G., translated), Bakteriofag i Fenomen Vyzdorovileniya. Tbilisi, Georgia: Tbilisi National University Publications, 1935.
17. Saunders, M.E., Bacteriophages in industrial fermentations, in Encyclopedia of Virology. Webster, R.G. and Granoff, A., Eds., San Diego: Academic Press, 1994, p. 116-121.
18. Ackermann, H.W. and DuBow, M.S., Viruses of prokaryotes I: general properties of bacteriophages, in Practical Applications of Bacteriophages. Boca Raton, FL: CRC Press, 1987, chap. 7.
19. Schlesinger M., Reindarstellung eines Bakteriophagen in mit freiem Auge sichtbaren Mengen, Biochem. Z., 264: 6, 1933.
20. Ruska H., Die Sichtbarmachung der Bakteriophagen Lyse im Übermikroskop, Naturwissenschaften, 28: 45-46, 1940.
21. Pfankuch, E. and Kausche, G., Isolierung U. Üebermikroskopische abbildung eines Bakteriophagen, Naturwissenschaften, 28: 46, 1940.
22. Ellis, E.L. and Delbrück, M., The growth of bacteriophage. J. Gen. Physiol., 22: 365-384, 1939.
23. Doermann, A.D., The intracellular growth of bacteriophages. I. Liberation of intracellular bacteriophage T4 by premature lysis with another phage or with cyanide, J. Gen. Physiol., 35: 645-356, 1952.
24. Cairns, J., Stent, G.S., and Watson, J.D., Phage and the Origins of Molecular Biology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1966.
25. Fischer, E. and Lipson, C., Thinking about Science: Max Delbrück and the Origins of Molecular Biology. New York: Norton, 1988.
26. Stent, G., Molecular Biology of Bacterial Viruses. San Francisco: W.H. Freeman, 1963, p. 8.
27. Appelmans, R., Le bacteriophage dans l’organisme, C. R. Seances Soc. Biol. Fil., 85: 722-724, 1921.
28. Evans, A.C., Inactivation of antistreptococcus bacteriophage by animal fluids. Public Health Reports, 48: 411-446, 1933. Cited by Merril, C. and Adhya, S., Phage Therapy, in The Bacteriophages. R. Calendar, Oxford University Press, 2006, p. 725-741.
29. Nungester, W.J. and Watrous, R.M., Accumulation of bacteriophage in spleen and liver following its intravenous inoculation, Proc. Soc. Exp. Biol. Med., 31: 901-905, 1934.
30. Geier, M.R., Trigg, M.E., and Merril, C.R., Fate of bacteriophage lambda in non-immune germ-free mice, Nature, 246: 221-223, 1973.
31. Dubos, R.J., Straus, J.H., and Pierce, C., The multiplication of bacteriophage in vivo and its protective effects against an experimental infection with Shigella dysenteriae, J. Exp. Med., 78: 161-168, 1943.
32. Morton, H.E. and Engely, F.B., Dysentery bacteriophage: review of the literature on its prophylactic and therapeutic uses in man and in experimental infections in animals, J. Am. Med. Assoc., 127: 584-591, 1945.
33. Ward, W.E., Protective action of VI bacteriophage in Eberthella typhi infections in mice, J. Infect. Dis., 72: 172-176, 1943.
34. Knouf, E.G., Ward, W.E., Reichle, P.A., Bower, A.G., and Hamilton, P.M., Treatment of typhoid fever with type specific bacteriophage, J. Am. Med. Assoc., 132: 134-138, 1946.
35. Desranleu, J.-M., Progress in the treatment of typhoid fever with VI phages, Can. J. Public Health, 473-478, 1949.
36. McGrath, S. and van Sinderen, D., Eds., Bacteriophage Genetics and Molecular Biology. Norfolk, U.K.: Caister Academic Press, 2007.
37. Vieu, J.F., Les bacteriophages. In Fabre J, Ed. Traite de Therapeutique, Vol. Serums et Vaccins. Paris:Flammarion, p. 337-340b, 1975.
38. Vieu, J.F., Guillermet, F., Minck, R., and Nicolle, P., Données actuelles sur les applications therapeutiques des bacteriophages. Bull. Acad. Natl. Med., 163: 61-66, 1979.
39. Slopek, S., Durlakova, I., Weber-Dabrowska, B., Kucharewicz-Krukowska, A., Dabrowski, M., and Bisikiewicz, R., Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results, Arch. Immunol. Ther. Exp., 31: 267-291, 1983.
40. Slopek, S., Kucharewica-Krukowska, A., Weber-Dabrowska, B., and Dabrowski, M., Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections, Arch. Immunol. Ther. Exp., 33: 261-273, 1985.
41. Slopek, S., Weber-Dabrowska, B., Dabrowski, M., and Kucharewica-Krukowska, A., Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986, Arch. Immunol. Ther. Exp., 35: 569-583, 1987.
42. Weber-Dabrowska, B., Dabrowski, M., and Slopek, S., Studies on bacteriophage penetration in patients subjected to phage therapy, Arch. Immunol. Ther. Exp. (Warsz), 35: 363-368, 1987.
43. Smith, H.W. and Huggins, M.B., Successful treatment of experimental E. coli infections in mice using phage: its general superiority over antibiotics, J. Gen. Microbiol., 128: 307-318, 1982.
44. Smith, H.W. and Huggins, M.B., Effectiveness of phages in treating experimental E. coli diarrhea in calves, piglets and lambs. J. Gen. Microbiol., 129: 2659-2675, 1983.
45. Smith, H.W. and Huggins, M.B., The control of experimental E. coli diarrhea in calves by means of bacteriophage, J. Gen. Microbiol., 133: 1111-1126, 1987.
46. Smith, H.W., Huggins, M.B., and Shaw, K.M., Factors influencing the survival and multiplication of bacteriophages in calves and in their environment, J. Gen. Microbiol., 133: 1127-1135, 1987.
47. Weber-Dabrowska, B., Mulczyk, M., and Gorski, A., Bacteriophage therapy of bacterial infections: an update of our institute’s experience, Arch. Immunol. Ther. Exp., 48: 547-551, 2000.
48. Weber-Dabrowska, B., Zimecki, M., Mulczyk, M., and Gorski, A., Effect of phage therapy on the turnover and function of peripheral neutrophils, FEMS Immunol. Med. Microbiol., 34: 135-138, 2002.
49. Miedzybrodzki, R., Fortuna, W., Weber-Dabrowska, B., Górski, A., Phage therapy of staphylococcal infections (including MRSA) may be less expensive than antibiotic treatment, Postepy Hig. Med. Dosw. (online), 61: 461-465, 2007, www.phmd.pl e-ISSN 1732-2693.
50. Katsarava, R., Beridze, V., Arabuli, N., Kharadze, D., Chu, C.C., and Won, C.Y., Amino acid-based bioanalogous polymers. Synthesis, and study of regular poly(ester amide)s based on bis(α-amino acid) α, β-alkylene diesters, and aliphatic dicarboxylic acids, J. Polymer Sci., 37: 391-407, 1999.
51. Markoishvili, K., Tsitlanadze, G., Katsarava, R., Morris, J.G. Jr., and Sulakvelidze, A., A novel sustained- release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds, Int. J. Dermatol., 41: 453-458, 2002.
52. Fekety, R. Antibiotic-associated diarrhea and colitis, Curr. Opin. Infect. Dis., 8: 391-397, 1995.
53. Merril, C.R., Biswis, B., Carlton, R., Jensen, N.C., Creed, G.J., Zullo, S., and Adhya, S., Long-circulating bacteriophages as antibacterial agents, Proc. Natl. Acad. Sci. U.S.A., 93: 3188-3192, 1996.
54. Greenwald, D. and Brandt, L., Recognizing E. coli O157:H7 infection, Hosp. Pract. (Off. Ed.), 32:123-126, 129-130, 133, 1997.
55. Raya, R.R., Varey, P., Oot, R.A., Dyen, M.R., Callaway, T.R., Edrington, T.S., Kutter, E.M., and Brabban, A.D., Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheep, Appl. Environ. Microbiol., 72:6405-6410, 2006.
56. Brabban, A.D., Nelson, D.A., Kutter, E., Edrington, T.S., and Callaway, T.R., Approaches to controlling Escherichia coli O157:H7, a food-borne pathogen and an emerging environmental hazard, Environ. Pract., 6: 208-229, 2004.
57. Ackermann, H. and Krisch, H., A catalogue of T4-type bacteriophages, Arch. Virol., 142: 2329-2345, 1997.
58. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., et al., Isolation of T4-like bacteriophages from the stool of pediatric diarrhea patients in Bangladesh, J. Bacteriol., 186: 8287-8294, 2004.
59. Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., et al., In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy, Antimicrob. Agents Chemother., 48: 2558-2569, 2004.
60. Kutter, E., Kellenberger, E., Carlson, K., et al., Effects of bacterial growth conditions and physiology on T4 infection, in Karam, J.D. and Drake, J., Eds., Molecular Biology of Bacteriophage T4. Washington, DC: American Society for Microbiology, 1994, p. 406-420.
61. Kutter, E., Stidham, T., Guttman, B., et al., Genomic map of bacteriophage T4, in Karam, J.D. and Drake, J., Eds. Molecular Biology of Bacteriophage T4. Washington, D.C.: American Society for Microbiology, 1994, p. 491-519.
62. Nolan, J.M., Petrov, V., Bertrand, C., Krisch, H.M., and Karam, J.D. Genetic diversity among five T4- like bacteriophages, Virol. J., 3: 30, 2006.
63. Kutter, E., Gachechiladze, K., Poglazov, A., Marusich, E., Aronsson, P., Napuli, A., et al., Evolution of T4-related phages, Virus Genes, 11: 285-297, 1995.
64. Henning, U. and Hashemolhosseini, S., Receptor recognition by T-even-type coliphages, in Karam, J.D. and Drake, J., Eds., Molecular Biology of Bacteriophage T4. Washington, DC: American Society for Microbiology, 1994, p. 291-298.
65. Tetart, F., Desplats, C., and Krisch, H.M., Genome plasticity in the distal tail fiber locus of the T-even bacteriophage: recombination between conserved motifs swaps adhesin specificity, J. Mol. Biol., 282:543-556, 1998.
66. Doermann, A.H., Lysis and lysis inhibition with E. coli bacteriophage, J. Bacteriol., 55: 257-275, 1948.
67. Abedon, S., Lysis and the interaction between free phages and infected cells, in Karam, J.D. and Drake, J., Eds., Molecular Biology of Bacteriophage T4. Washington, DC: American Society for Microbiology, 1994, p. 397-405.
68. Kolter, R., Life and death in stationary phase, ASM News, 58: 75-79, 1992.
69. O’Flaherty, S., Coffey, A., Edwards, R., Meaney, W., Fitzgerald, G.F., and Ross, R.P., Genome of staphylococcal phage K: a new lineage of Myoviridae infecting Gram-positive bacteria with a low G+C content, J. Bacteriol., 186: 2862-2871, 2004.
70. Bergh, O., Borsheim, K.Y., Bratbak, G., et al., High abundance of viruses found in aquatic environments, Nature, 340: 467-468, 1989.
71. Caldwell, J.A., Bacteriologic and bacteriophagic study of infected urines, J. Infect. Dis., 43: 353-362, 1928.
72. Yeung, M.K. and Kozelsky, C.S. Transfection of Actinomyces spp. by genomic DNA of bacteriophages from human dental plaque, Plasmid, 37: 141-153, 1997.
73. Bachrach, G., Leizerovici-Zigmond, M., Zlotkin, A., et al., Bacteriophage isolation from human saliva, Lett. Appl. Microbiol., 36: 50-53, 2003.
74. Merril, C.R., Friedman, T.B., Attallah, A.F., et al., Isolation of bacteriophages from commercial sera, In Vitro, 8: 91-93, 1972.
75. Geier, M.R., Attallah, A.F., and Merril, C.R., Characterization of Escherichia coli bacterial viruses in commercial sera, In Vitro, 11: 55-58, 1975.
76. Milch, H. and Fornosi, F., Bacteriophage contamination in live poliovirus vaccine, J. Biol. Stand., 3:307-310, 1975.
77. Moody, E.E., Trousdale, M.D., Jorgensen, J.H., et al., Bacteriophages and endotoxin in licensed livevirus vaccines, J. Infect. Dis., 131: 588-591, 1975.
78. Bogovazova, G.G., Voroshilova, N.N., and Bondarenko, V.M., The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection, Zh. Mikrobiol. Epidemiol. Immunobiol., 1991, p. 5-8.
79. Bogovazova, G.G., Voroshilova, N.N., Bondarenko, V.M., et al., Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages, Zh. Mikrobiol. Epidemiol. Immunobiol., 1992, p. 30-33.
80. Larkum, N.W., Bacteriophage as a substitute for typhoid vaccine, J. Bacteriol., 17: 42, 1929.
81. Larkum, N.W. Bacteriophage from Public Health standpoint, Am. J. Pub. Health, 19: 31-36, 1929.
82. King, W.E., Boyd, D.A., and Conlin, J.H., The cause of local reactions following the administration of Staphylococcus bacteriophage, Am. J. Clin. Pathol., 4: 336-345, 1934.